El interés en corto de Kaixin Hldgs da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Kaixin Hldgs. Los datos de interés en corto se actualizan cada dos semanas.

Kaixin Hldgs (NASDAQ:KXIN) Bolsa, Informe de interés en corto

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

Kaixin Holdings

Kaixin Auto Holdings Warrants (30/04/2024)

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Entrada Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRDA#NASDAQ">TRDA</a>) with a Buy and maintains $20 price target.

News

Price Target

Reiteration

Analyst Ratings

TRDA

HC Wainwright & Co. Reiterates Buy on Entrada Therapeutics, Maintains $20 Price Target

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Alpha Cognition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACOG#NASDAQ">ACOG</a>) with a Buy and maintains $20 price target.

ACOG

HC Wainwright & Co. Reiterates Buy on Alpha Cognition, Maintains $20 Price Target

General

EVTL

Vertical Aerospace To Adopt Combined Charging Standard (CCS) To Boost eVTOL Deployment

Chicago Atlantic BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIEN#NASDAQ">LIEN</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.29 by 20.69 percent. This is a 25 percent increase over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $12.65 million which beat the analyst consensus estimate of $11.00 million by 14.98 percent. This is a 251.33 percent increase over sales of $3.60 million the same period last year.

Earnings

Earnings Beats

LIEN

Chicago Atlantic BDC Q4 Net Investment Income per share  $0.35 Beats $0.29 Estimate, Total investment income $12.65M Beat $11.00M Estimate

GORV

Lazydays Signs Letter Of Intent To Divest Three Store Locations To General RV Center

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) with a Buy and maintains $42 price target.

AVXL

HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $42 Price Target

HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintains Soleno Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNO#NASDAQ">SLNO</a>) with a Buy and raises the price target from $70 to $100.

SLNO

HC Wainwright & Co. Maintains Buy on Soleno Therapeutics, Raises Price Target to $100

On Friday, March 28th, U.S. markets closed sharply lower as fears of slowing economic growth, rising inflation, and escalating tariffs under the Trump administration weighed on markets. Major tech stocks like Amazon, Microsoft, and Apple tumbled.
Consumer spending disappointed, inflation expectations surged, and investors grew cautious ahead of new tariffs. Markets anticipate possible interest rate cuts by the Federal Reserve.
In economic data, the Fed&#8217;s preferred inflation gauge — the core PCE price index — rose 2.8% year-over-year in February, above the 2.7% forecast. Investor concerns grew as the University of Michigan survey showed 5-year inflation expectations rising to 4.1%, the highest since February 1993.
Most S&amp;P 500 sectors ended lower, led by losses in consumer discretionary, communication services, and tech stocks. Utilities were the exception, closing higher and defying the broader market downturn.
The Dow Jones Industrial Average was down 1.69% at 41,583.90, the S&amp;P 500 slid 1.97% to 5,580.94, and the Nasdaq Composite fell 2.70% to 17,322.99.
Asia Markets Today
<ul>
<li>On Monday, Japan&#8217;s Nikkei 225 closed the session drastically lower by 4.03% at 35,624.50, led by losses in the Shipbuilding, Manufacturing, and Services sectors.</li>
<li>Japan&#8217;s Nikkei 225 plunged 4.05%, entering correction territory with a nearly 12% drop from its December peak, driven by fears over U.S. tariffs.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 was down 1.74% and closed at 7,843.40, led by losses in the Metals &amp; Mining, Resources and Materials sectors.</li>
<li>India markets closed for the Ramzan (Id-Ul-Fitar) holiday.</li>
<li>China&#8217;s Shanghai Composite declined 0.46% to 3,335.75, and the Shanghai Shenzhen CSI 300 slid 0.71% to 3,887.31.</li>
<li>Hong Kong&#8217;s Hang Seng was down 1.31%, ending the session at 23,119.58.</li>
</ul>
Eurozone at 05:45 AM ET
<ul>
<li>The European STOXX 50 was down 1.37%.</li>
<li>Germany&#8217;s DAX declined 1.27%.</li>
<li>France&#8217;s CAC slid 1.37%.</li>
<li>U.K.&#8217;s FTSE 100 index traded lower by 0.98%.</li>
<li>European stocks fell sharply as investors braced for U.S. tariffs, which are set to take effect Wednesday. Fears of broader trade measures raised recession risks and pressured global markets and oil prices.</li>
</ul>
Commodities at 05:45 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 0.23% at $69.52/bbl, and Brent was up 0.23% at $72.93/bbl.</li>
<li>Oil prices rose after Trump threatened 25–50% tariffs on Russian oil buyers, but gains were limited as traders doubted the seriousness of the move. Analysts cited market fatigue over U.S. sanctions talk.</li>
<li>Natural Gas rose 03.12% to $4.192.</li>
<li>Gold was trading higher by 1.02% at $3,146.11, Silver was up 0.15% to $34.868, and Copper slid 1.80% to $5.0375.</li>
<li>Gold surged to a record high on Monday, marking its third straight session of gains, as investors sought safety amid rising tariff uncertainty and inflation fears.</li>
</ul>
U.S. Futures at 05:45 AM ET
Dow futures were down 0.59%, S&amp;P 500 futures declined 0.87% and Nasdaq 100 futures fell 1.25%.
Forex at 05:45 AM ET
<ul>
<li>The U.S. Dollar Index fell 0.22% to 104.03, USD/JPY was down 0.44% to 149.17, and USD/AUD gained 0.57% to 1.5990.</li>
<li>The U.S. dollar held steady Monday but is set for a quarterly loss of over 4% amid fears that Trump&#8217;s tariff plans will stoke inflation and hurt growth.</li>
</ul>
Image via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Japan's Index Falls In Correction Territory, Europe Declines On Trade Fears; Gold Surges To New Record - Global Markets Today While US Slept

Unicycive Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNCY#NASDAQ">UNCY</a>) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.50) by 12 percent. This is a 56.25 percent increase over losses of $(1.28) per share from the same period last year.

UNCY

Unicycive Therapeutics FY 2024 GAAP EPS $(0.56) Misses $(0.50) Estimate, As Of December 31, 2024, Cash And Cash Equivalents Of $26.1M, Sufficient To Fund Planned Operations Into 2026

D-Wave Quantum Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) ("D-Wave" or the "Company"), a leader in quantum computing systems, software, and services, and Ford Otosan, a joint venture between Ford Motor Company and Koç Holding in Turkey, today announced that the vehicle manufacturer has deployed a hybrid-quantum application in production, streamlining manufacturing processes for its Ford Transit line of vehicles. The application, which uses D-Wave's annealing quantum computing technology, has improved vehicle production sequencing at Ford Otosan, a powerful demonstration of quantum computing's real-world impact in automotive manufacturing.

QBTS

Ford Otosan Uses Quantum Tech from D-Wave to Speed Up Transit Van Production

Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) reported quarterly losses of $(11.23) per share which missed the analyst consensus estimate of $(10.01) by 12.19 percent. This is a 49.21 percent increase over losses of $(22.11) per share from the same period last year. The company reported quarterly sales of $15.77 million which missed the analyst consensus estimate of $17.00 million by 7.26 percent. This is a 13.05 percent decrease over sales of $18.13 million the same period last year.

Earnings Misses

VERO

Venus Concept Q4 2024 GAAP EPS $(11.23) Misses $(10.01) Estimate, Sales $15.77M Miss $17.00M Estimate

LM Funding America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMFA#NASDAQ">LMFA</a>) reported quarterly losses of $(0.86) per share. This is a 28.36 percent decrease over losses of $(0.67) per share from the same period last year. The company reported quarterly sales of $1.985 million which beat the analyst consensus estimate of $1.500 million by 32.33 percent. This is a 51.05 percent decrease over sales of $4.055 million the same period last year.

LMFA

LM Funding America Q4 2024 GAAP EPS $(0.86) Down From $(0.67) YoY, Sales $1.985M Beat $1.500M Estimate

Lazydays Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) reported quarterly losses of $(2.39) per share. This is a 119.27 percent decrease over losses of $(1.09) per share from the same period last year. The company reported $159.88 million in sales this quarter. This is a 19.26 percent decrease over sales of $198.03 million the same period last year.

Lazydays Hldgs Q4 EPS $(2.39) Down From $(1.09) YoY, Sales $159.88M Down From $198.03M YoY

D-Wave Quantum Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) ("D-Wave" or the "Company"), a leader in quantum computing systems, software, and services, and the pharmaceutical division of Japan Tobacco Inc. ("JT") today announced the completion of a joint proof-of-concept project that used quantum computing technology and artificial intelligence (AI) in the drug discovery process. JT and D-Wave enhanced large language models (LLMs) with a quantum-hybrid workflow to increase their generative capabilities and enable JT to produce novel, more "drug-like" molecular structures beyond those found in the training datasets for the quantum-hybrid generative AI system.

D-Wave and Japan Tobacco Use Quantum Tech and AI to Boost Drug Discovery

HC Wainwright &amp; Co. analyst Yi Chen reiterates Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) with a Buy and maintains $6 price target.

CLSD

HC Wainwright & Co. Reiterates Buy on Clearside Biomedical, Maintains $6 Price Target

WKHS

Workhorse Gr FY 2024 GAAP EPS $(51.69) Misses $(30.44) Estimate, Sales $6.616M Miss $7.750M Estimate

Brainstorm Cell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCLI#NASDAQ">BCLI</a>) reported quarterly losses of $(2.31) per share which beat the analyst consensus estimate of $(2.56) by 9.77 percent. This is a 61.5 percent increase over losses of $(6.00) per share from the same period last year.

BCLI

Brainstorm Cell FY 2024 GAAP EPS $(2.31) Beats $(2.56) Estimate

HC Wainwright &amp; Co. analyst Yi Chen initiates coverage on Virax Biolabs Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAX#NASDAQ">VRAX</a>) with a Buy rating and announces Price Target of $3.

Initiation

VRAX

HC Wainwright & Co. Initiates Coverage On Virax Biolabs Group with Buy Rating, Announces Price Target of $3

MediPharm Labs (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MEDIF#OTC">MEDIF</a>) will report on Q4 2024.

MEDIF

MediPharm Labs FY 2024 Revenue CAD 45.205M up from 36.819M YoY and EPS CAD (0.03) up from (0.04) YoY

<a href="https://www.globenewswire.com/Tracker?data=uMMr_JNGQ1NBRyWksbBDXW6Tszs_J7dBSNi0E_RpIRVoNI3eDcRg8RkZ7UA6KtFsDVJ6naoP-aBjVnF2cZ9kk6iEYAKW38n5fFgoLy6PGEU=">LPL Financial Holdings Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>) (together with its subsidiaries, including LPL Financial LLC, "LPL Financial" or "LPL") today announced that it has commenced an underwritten public offering of $1.5 billion of its common stock.
Morgan Stanley &amp; Co. LLC is acting as sole active book-running manager. LPL also intends to grant the underwriters a 30-day option to purchase up to an additional $225.0 million of its common stock.
LPL intends to use the net proceeds of this offering to fund a portion of the cash consideration payable in connection with its previously announced proposed acquisition of Commonwealth Financial Network (the "Transaction") and, to the extent that any proceeds remain thereafter, or if the Transaction is not completed, for general corporate purposes. In addition to the net proceeds from this offering, LPL expects to use available cash and other borrowings to fund the purchase price for the Transaction.

Comments

Kaixin Hldgs

Interés en corto

Kaixin Hldgs (NASDAQ:KXIN) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL